Suppr超能文献

克罗恩病患者亲属及配偶的不同肠道通透性模式:黏膜防御方面的遗传性缺陷?

Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence?

作者信息

Söderholm J D, Olaison G, Lindberg E, Hannestad U, Vindels A, Tysk C, Järnerot G, Sjödahl R

机构信息

Department of Surgery, University Hospital, Linköping, Sweden.

出版信息

Gut. 1999 Jan;44(1):96-100. doi: 10.1136/gut.44.1.96.

Abstract

BACKGROUND

A familial defect in intestinal barrier function has been found in Crohn's disease.

AIM

To investigate possible genetic and environmental influences on this barrier defect by studying intestinal permeability in both relatives and spouses of patients with Crohn's disease.

SUBJECTS

The study included 39 patients with Crohn's disease, 34 healthy first degree relatives, and 22 spouses. Twenty nine healthy volunteers served as controls.

METHODS

Intestinal permeability was assessed as the lactulose:mannitol ratio in five hour urinary excretion after oral load, both before (baseline) and after ingestion of acetylsalicylic acid. The permeability response represents the difference between the two tests. A ratio above the 95th percentile for controls was classified as abnormal.

RESULTS

Baseline permeability was higher in patients and spouses than in controls. An abnormal baseline permeability was seen in 36% of the patients, 23% of the spouses, 18% of the relatives, and 3% of the controls. After ingestion of acetylsalicylic acid, permeability increased significantly in all groups. Relatives were similar to patients with regard to permeability after exposure to acetylsalicylic acid, whereas spouses were similar to controls. The proportions with an abnormal permeability response to acetylsalicylic acid were 32% in patients, 14% in spouses, 41% in relatives, and 3% in controls. CONCLUSION The findings suggest that baseline permeability is determined by environmental factors, whereas permeability provoked by acetylsalicylic acid is a function of the genetically determined state of the mucosal barrier, and support the notion that environmental and hereditary factors interact in the pathogenesis of Crohn's disease.

摘要

背景

在克罗恩病中发现了肠道屏障功能的家族性缺陷。

目的

通过研究克罗恩病患者的亲属和配偶的肠道通透性,调查可能对这种屏障缺陷产生影响的遗传和环境因素。

对象

该研究纳入了39例克罗恩病患者、34名健康的一级亲属和22名配偶。29名健康志愿者作为对照。

方法

肠道通透性通过口服负荷后5小时尿液排泄中的乳果糖:甘露醇比值来评估,分别在服用乙酰水杨酸之前(基线)和之后进行。通透性反应代表两次测试之间的差异。高于对照组第95百分位数的比值被归类为异常。

结果

患者和配偶的基线通透性高于对照组。36%的患者、23%的配偶、18%的亲属和3%的对照出现异常基线通透性。服用乙酰水杨酸后,所有组的通透性均显著增加。在接触乙酰水杨酸后,亲属在通透性方面与患者相似,而配偶与对照组相似。对乙酰水杨酸通透性反应异常的比例在患者中为32%,在配偶中为14%,在亲属中为41%,在对照中为3%。结论:研究结果表明基线通透性由环境因素决定,而乙酰水杨酸引发的通透性是黏膜屏障遗传决定状态的函数,并支持环境和遗传因素在克罗恩病发病机制中相互作用的观点。

相似文献

引用本文的文献

1
The epithelium takes the stage in asthma and inflammatory bowel diseases.上皮细胞在哮喘和炎症性肠病中发挥着重要作用。
Front Cell Dev Biol. 2024 Mar 11;12:1258859. doi: 10.3389/fcell.2024.1258859. eCollection 2024.
3
Deciphering the different phases of preclinical inflammatory bowel disease.解析临床前炎症性肠病的不同阶段。
Nat Rev Gastroenterol Hepatol. 2024 Feb;21(2):86-100. doi: 10.1038/s41575-023-00854-4. Epub 2023 Nov 10.
7
Oral Delivery of Biologics via the Intestine.生物制剂经肠道的口服给药
Pharmaceutics. 2020 Dec 24;13(1):18. doi: 10.3390/pharmaceutics13010018.
8
Exploring the Early Phase of Crohn's Disease.探索克罗恩病的早期阶段。
Clin Gastroenterol Hepatol. 2021 Dec;19(12):2469-2480. doi: 10.1016/j.cgh.2020.09.023. Epub 2020 Sep 16.
9
Diagnosis and natural history of preclinical and early inflammatory bowel disease.临床前及早期炎症性肠病的诊断与自然史
Ann Gastroenterol. 2020 Sep-Oct;33(5):443-452. doi: 10.20524/aog.2020.0508. Epub 2020 Jun 22.

本文引用的文献

4
The genetics of inflammatory bowel disease.炎症性肠病的遗传学
Gut. 1997 May;40(5):572-4. doi: 10.1136/gut.40.5.572.
7
Crohn's disease: a family affair.克罗恩病:家族性疾病
Gastroenterology. 1996 Sep;111(3):813-5. doi: 10.1053/gast.1996.v111.agast961110813.
8
Epidemiology of inflammatory bowel disease: an update.炎症性肠病的流行病学:最新进展
Scand J Gastroenterol. 1996 May;31(5):417-27. doi: 10.3109/00365529609006759.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验